Intellectual property rights and Indian pharmaceutical industry: Present scenario.
作者信息
Prakash Ajay, Sarma Phulen, Kumar Subodh, Medhi Bikash
机构信息
Department of Pharmacology, PGIMER, Chandigarh, India.
出版信息
Indian J Pharmacol. 2018 Mar-Apr;50(2):57-60. doi: 10.4103/ijp.IJP_320_18.
Abstract
摘要
相似文献
1
Intellectual property rights and Indian pharmaceutical industry: Present scenario.知识产权与印度制药行业：现状
Indian J Pharmacol. 2018 Mar-Apr;50(2):57-60. doi: 10.4103/ijp.IJP_320_18.
2
India must respect intellectual property rights, report says.报告称，印度必须尊重知识产权。
BMJ. 2013 Jul 18;347:f4618. doi: 10.1136/bmj.f4618.
3
The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India.《与贸易有关的知识产权协定》对创新和出口的影响：以印度制药业为例的研究
Indian J Med Ethics. 2008 Apr-Jun;5(2):61-5. doi: 10.20529/IJME.2008.023.
4
Drug patents and intellectual property rights.药品专利与知识产权。
Eur J Clin Pharmacol. 2015 Apr;71(4):403-9. doi: 10.1007/s00228-015-1811-5. Epub 2015 Feb 3.
5
10 years after implementation of TRIPS obligations in India.印度实施《与贸易有关的知识产权协定》（TRIPS）义务10年后。
Pharm Pat Anal. 2015;4(3):147-59. doi: 10.4155/ppa.15.12.
6
Big-pharmaceuticalisation: clinical trials and Contract Research Organisations in India.大型制药化：印度的临床试验与合同研究组织
Soc Sci Med. 2015 Apr;131:239-46. doi: 10.1016/j.socscimed.2014.11.052. Epub 2014 Nov 26.
7
Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals.《与贸易有关的知识产权协议》对作为通用抗逆转录病毒药物供应国的印度的影响。
J Pharm Sci. 2011 Mar;100(3):816-21. doi: 10.1002/jps.22326. Epub 2010 Aug 25.
8
How TRIPS benefits Indian industry and how it may not benefit the Indian people.《与贸易有关的知识产权协定》如何使印度工业受益，以及它可能如何无法使印度人民受益。
Indian J Med Ethics. 2008 Apr-Jun;5(2):66-9. doi: 10.20529/IJME.2008.024.
9
Patent wars: affordable medicines versus intellectual property rights.专利战争：平价药品与知识产权
BMJ. 2014 Feb 17;348:g1533. doi: 10.1136/bmj.g1533.
10
The ethics of intellectual property rights in an era of globalization.全球化时代的知识产权伦理
J Law Med Ethics. 2013 Winter;41(4):841-51, Table of Contents. doi: 10.1111/jlme.12094.
引用本文的文献
1
A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.全球知识产权豁免仍有必要，以解决新冠肺炎和未来大流行防范的不公平问题。
Inquiry. 2022 Jan-Dec;59:469580221124821. doi: 10.1177/00469580221124821.
2
Spinal Muscular Atrophy Therapeutics in India: Parental Hopes and Despair!印度的脊髓性肌萎缩症治疗方法：家长们的希望与绝望！
Ann Neurosci. 2021 Jul;28(3-4):112-113. doi: 10.1177/09727531211046365. Epub 2021 Oct 3.
3
Assessment of knowledge, attitude and practice regarding intellectual property rights among dental task force attending private dental colleges in Navi Mumbai: a cross-sectional study.孟买新市镇私立牙科学院牙科工作组成员对知识产权的知识、态度和实践评估：一项横断面研究。
J Med Life. 2021 Jan-Mar;14(1):93-99. doi: 10.25122/jml-2020-0103.
本文引用的文献
1
Compulsory licensing of patents in India.印度专利的强制许可
Pharm Pat Anal. 2016 Sep;5(6):401-406. doi: 10.4155/ppa-2016-0033. Epub 2016 Nov 2.
2
Patent watch: Drug patenting in India: looking back and looking forward.专利观察：印度的药品专利：回顾与展望
Nat Rev Drug Discov. 2015 Aug;14(8):519-20. doi: 10.1038/nrd4681. Epub 2015 Jul 17.
Zotero 插件